Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1996-04-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.93.8.3669PMID 8622994PMCID PMC39669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte-monocyte colony-stimulating factor, and interferon-gamma) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor.

  1995cited by this paper
• Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis

  1995cited by this paper
• Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses

  1995cited by this paper
• Antigen presentation to cytotoxic T lymphocytes in vivo

  1995cited by this paper
• Phagocyte‐induced antigen‐specific activation of unprimed CD8+ T cells in vitro

  1995cited by this paper
• A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides.

  1995cited by this paper
• A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

  1995cited by this paper
• Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96

  1995cited by this paper
• Structure of peptides associated with class I and class II MHC molecules.

  1994cited by this paper
• Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

  1994cited by this paper
• CD28-B7 interactions in T-cell activation.

  1994cited by this paper
• LacZ inducible, antigen/MHC-specific T cell hybrids.

  1994cited by this paper
• Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism.

  1993cited by this paper
• Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production

  1993cited by this paper
• Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells.

  1993cited by this paper
• Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression

  1992cited by this paper
• Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes

  1992cited by this paper
• Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure.

  1991cited by this paper
• The dendritic cell system and its role in immunogenicity.

  1991cited by this paper
• Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene.

  1991cited by this paper
• Mechanism of cytolytic T lymphocyte killing of a low class I-expressing tumor.

  1991cited by this paper
• The cell biology of antigen processing and presentation.

  1991cited by this paper
• Macrophages: current views on their differentiation, structure, and function.

  1989cited by this paper
• Antigen-specific T lymphocytes efficiently cluster with dendritic cells in the human primary mixed-leukocyte reaction.

  1988cited by this paper
• Introduction of soluble protein into the class I pathway of antigen processing and presentation.

  1988cited by this paper
• A human beta-actin expression vector system directs high-level accumulation of antisense transcripts.

  1987cited by this paper
• Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells.

  1986cited by this paper
• Stimulation of hematopoiesis in vivo by recombinant bacterial murine interleukin 3.

  1986cited by this paper
• Heterogeneity among macrophages cultured from mouse bone marrow

  1985cited by this paper
• Marginal zone macrophages identified by a monoclonal antibody: characterization of immuno- and enzyme-histochemical properties and functional capacities.

  1985cited by this paper
• Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2).

  1985cited by this paper
• Cell Surface Structures Involved in T Cell Activation

  1984cited by this paper
• Methods for using centrifugal elutriation to separate malignant and lymphoid cell populations.

  1984cited by this paper
• Haplotype-specific suppression of cytotoxic T cell induction by antigen inappropriately presented on T cells

  1983cited by this paper
• The DNA sequence of the H‐2kb gene: evidence for gene conversion as a mechanism for the generation of polymorphism in histocompatibilty antigens.

  1983cited by this paper
• I-A antigens on cloned alloreactive murine T lymphocytes are acquired passively.

  1982cited by this paper
• Localization of allodeterminants on H-2Kb antigens determined with monoclonal antibodies and H-2 mutant mice.

  1982cited by this paper
• Surface properties of bacillus Calmette-Guerin-activated mouse macrophages. Reduced expression of mannose-specific endocytosis, Fc receptors, and antigen F4/80 accompanies induction of Ia

  1981cited by this paper
• A monoclonal antibody discriminating between subsets of T and B cells.

  1981cited by this paper
• A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication.

  1981cited by this paper
• F4/80, a monoclonal antibody directed specifically against the mouse macrophage

  1981cited by this paper
• Antigens displayed on murine B lymphocyte precursors.

  1981cited by this paper
• H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes.

  1980cited by this paper
• Thymoma production of T cell growth factor (Interleukin 2).

  1980cited by this paper
• Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens *

  1979cited by this paper
• Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors

  1979cited by this paper
• Mac‐1: a macrophage differentiation antigen identified by monoclonal antibody

  1979cited by this paper
• Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay

  1976cited by this paper
• Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse spleen

  1975cited by this paper
• A direct relationship between immune competence and the subcutaneous growth rate of a malignant murine lung tumor.

  1974cited by this paper
• IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE

  1973cited by this paper

• Role of Interleukins in Pancreatic Cancer: A Literature Review

  2024cites this paper
• IL-3-driven T cell-basophil crosstalk enhances anti-tumor immunity

  2024cites this paper
• IL-3: key orchestrator of inflammation

  2024cites this paper
• Bacteria-Based Immune Therapies for Cancer Treatment.

  2021cites this paper
• Strong in vivo antitumor responses induced by an antigen immobilized in nanogels via reducible bonds.

  2016cites this paper
• Pro-oncogenic cytokines and growth factors are differentially expressed in the post-surgical wound fluid from malignant compared to benign breast lesions

  2015cites this paper
• single cell level Phagocytic dendritic cells from myelomas activate tumor-specific T cells at a

  2013cites this paper
• The Roles of Macrophages and Nitric Oxide in Interleukin-3-Enhanced HSV-Sr39tk-Mediated Prodrug Therapy

  2013cites this paper
• Investigation of endogenous antigen processing by delivery of an intact protein into cells.

  2008cites this paper
• CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells

  2007cites this paper
• Radiation-Induced Immune Modulation in Prostate Cancer

  2007cites this paper
• In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine

  2007cites this paper
• Tetracycline-regulated intratumoral expression of interleukin-3 enhances the efficacy of radiation therapy for murine prostate cancer

  2006cites this paper
• Absence of interleukin-3 does not affect the severity of local and systemic anaphylaxis but does enhance eosinophil infiltration in a mouse model of allergic peritonitis.

  2004cites this paper
• Cytokines in cancer pathogenesis and cancer therapy

  2004cites this paper
• Immunotherapy for Human Cancer

  2004cites this paper
• Cutting Edge: CD8+ Effector T Cells Reject Tumors by Direct Antigen Recognition but Indirect Action on Host Cells1

  2003cites this paper
• G-CSF, GM-CSF, and IL-3 Knockout Mice

  2003cites this paper
• Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.

  2003influential citation
• Indirect Action on Host Cells Tumors by Direct Antigen Recognition but Effector T Cells Reject + Cutting Edge: CD8

  2003cites this paper
• Derived CD 4 T Cell Epitopes Listeria monocytogenes Cross-Presentation of Geginat

  2002cites this paper
• Cross-Presentation of Listeria monocytogenes-Derived CD4 T Cell Epitopes1

  2002cites this paper
• Generation of CD8+ T cell immunity with help from CD4+ T cells

  2002cites this paper
• Immunologic Targets for the Gene Therapy of Cancer

  2002cites this paper
• [Effect of electromagnetic waves in the centimeter range on the production of tumor necrosis factor and interleukin-3 in immunized mice].

  2002cites this paper
• Dendritic Cell–Dead Cell Interactions: Implications and Relevance for Immunotherapy

  2001cites this paper
• Adenovirus-Mediated Interleukin 3β Gene Transfer by Isolated Limb Perfusion Inhibits Growth of Limb Sarcoma in Rats

  2001cites this paper
• Cross-presentation, dendritic cells, tolerance and immunity.

  2001cites this paper
• Tumours can act as adjuvants for humoral immunity

  2001cites this paper
• Dendritic Cells Transduced with HSV-1 Amplicons Expressing Prostate-Specific Antigen Generate Antitumor Immunity in Mice

  2001cites this paper
• Development of a Novel Methodology for Improving CTL Recognition of Prostate Specific Antigen (PSA) for the Immunotherapy of Prostate Cancer

  2001cites this paper
• Phagocytic dendritic cells from myelomas activate tumor-specific T cells at a single cell level.

  2001cites this paper
• T-cell antigen discovery (T-CAD) assay: a novel technique for identifying T cell epitopes.

  2001cites this paper
• MHC Class II Presentation of Endogenous Tumor Antigen by Cellular Vaccines Depends on the Endocytic Pathway but not H2‐M

  2000cites this paper
• Interleukin-3 and stress.

  2000cites this paper
• Anergy Antigen-Specific T Cell Priming Followed by the Conjunctiva Elicits Prolonged Antigen Introduced Through the Mucosa of During Mucosal Tolerance Induction : In Vivo Behavior of Peptide-Specific T Cells

  2000cites this paper
• Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo

  2000cites this paper
• Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.

  2000cites this paper
• Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model.

  2000cites this paper
• Tumor Cells Present MHC Class II-Restricted Nuclear and Mitochondrial Antigens and Are the Predominant Antigen Presenting Cells In Vivo1

  2000cites this paper
• Alteration of tumour response to radiation by interleukin-2 gene transfer

  2000cites this paper
• Combining radiation therapy with interleukin-3 gene immunotherapy

  2000cites this paper
• Bacterial Proteins Can Be Processed by Macrophages in a Transporter Associated with Antigen Processing-Independent, Cysteine Protease-Dependent Manner for Presentation by MHC Class I Molecules1

  2000cites this paper
• In Vivo Behavior of Peptide-Specific T Cells During Mucosal Tolerance Induction: Antigen Introduced Through the Mucosa of the Conjunctiva Elicits Prolonged Antigen-Specific T Cell Priming Followed by Anergy1

  2000cites this paper
• Mechanisms mediating the effects of IL‐3 gene expression on tumor growth

  2000cites this paper
• A Bone Marrow-Derived APC in the Gut-Associated Lymphoid Tissue Captures Oral Antigens and Presents Them to Both CD4+ and CD8+ T Cells1

  2000cites this paper
• Antitumor Immunity as Therapy for Human Cancer

  2000cites this paper
• Chapter 1 – Regulation of Mast Cell and Basophil Development by Stem Cell Factor and Interleukin-3

  2000cites this paper
• A Bone Marrow-Derived APC in the Gut-Associated Lymphoid Tissue Captures Oral Antigens and Presents Them to Both CD4 and CD8 T Cells

  2000cites this paper
• AnergyAntigen-Specific T Cell Priming Followed by the Conjunctiva Elicits Prolonged Antigen Introduced Through the Mucosa of During Mucosal Tolerance Induction: In Vivo Behavior of Peptide-Specific T Cells

  2000cites this paper
• Cytotoxic T lymphocyte activation by cross-priming.

  1999cites this paper
• The Regulation of Mast Cell and Basophil Development by the Kit Ligand, SCF, and IL-3

  1999cites this paper
• Adjuvants that enhance priming of cytotoxic T cells to a Kb-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigen.

  1999cites this paper
• Cell‐based vaccines for the stimulation of immunity to metastatic cancers

  1999cites this paper
• Interleukin‐3 and granulocyte–macrophage colony‐stimulating factor enhance the generation and function of dendritic cells

  1999cites this paper
• Enhancing the Immunogenicity of Exogenous Hepatitis B Surface Antigen-Based Vaccines for MHC-I-Restricted T Cells

  1999cites this paper
• Cells and cytokines in immunotherapy and gene therapy of cancer.

  1999cites this paper
• IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytes.

  1998cites this paper
• A transgenic strategy for analyzing the regulatory regions of the human prostate-specific antigen gene: potential applications for the treatment of prostate cancer (Review).

  1998cites this paper
• MHC Class II-Transfected Tumor Cells Directly Present Antigen to Tumor-Specific CD4+ T Lymphocytes1

  1998cites this paper
• Tumor immunotherapy: cytokines and antigen presentation

  1998cites this paper
• Altered peptide ligand design: altering immune responses to class I MHC/peptide complexes

  1998cites this paper
• Involvement of interleukin-3 in delayed-type hypersensitivity.

  1998cites this paper
• Cross-tolerance: A Pathway for Inducing Tolerance to Peripheral Tissue Antigens

  1998cites this paper
• T Lymphocytes Generation of Primary Tumor-Specific Cytolytic Major Histocompatibility Antigen and Particulate Antigen in Association with Class I IL-3 Enhances Both Presentation of Exogenous

  1998cites this paper
• IL-1/IL-3 gene therapy of non-small cell lung cancer (NSCLC) in rats using ‘cracked’ adenoproducer cells

  1998cites this paper
• Lymphocytes T + Present Antigen to Tumor-Specific CD 4 MHC Class II-Transfected Tumor Cells Directly Ostrand-Rosenberg

  1998cites this paper
• MHC class II-transfected tumor cells directly present antigen to tumor-specific CD4+ T lymphocytes.

  1998cites this paper
• Tumor antigen presentation: changing the rules

  1998cites this paper
• Immunotherapy of established tumor with MHC class II and B7.1 cell-based tumor vaccines.

  1998cites this paper
• Similar as well as distinct MHC class I‐binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen

  1998cites this paper
• Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines.

  1998cites this paper
• IL-3-mediated enhancement of particulate antigen presentation by macrophages.

  1998cites this paper
• Reading within the lines: naturally processed peptides displayed by MHC class I molecules.

  1998cites this paper
• Construction and characterization of vaccinia direct ligation vectors.

  1997cites this paper
• Genetic modification of a carcinoma with the IL‐4 gene increases the influx of dendritic cells relative to other cytokines

  1997cites this paper
• The host-tumor immune conflict: from immunosuppression to resistance and destruction.

  1997cites this paper
• B7‐1‐dependent co‐stimulation results in qualitatively and quantitatively different responses by CD4+ and CD8+ T cells

  1997cites this paper
• Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation.

  1997cites this paper
• Cancer gene therapy and immunotherapy (review).

  1996cites this paper
• Special delivery for peptide-stimulated immunity

  1996cites this paper